Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong

References

• Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002;8:160–6.
   PubMed Web of Science ®Google Scholar
• Meatherall BL, Gregson D, Ross T, Pitout PDD, Laupland KB. Incidence, risk factors and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 2009;122: 866–73.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006;50:498–504.
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, et al. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006;21:816–22.
   PubMed Web of Science ®Google Scholar
• Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacillin isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART. J Antimicrob Chemother 2006;58:205–10.
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003;37:745–51.
   PubMed Web of Science ®Google Scholar
• McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP Jr, et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 2007;45:329–37.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Ko WC, Gottberg AV, Mohapatra S, Casellas JM, Goossens H, et al. International prospective study of Klebsiella pneumoniae bacteremia: implication of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 2004;140:26–32.
   PubMed Web of Science ®Google Scholar
• Government of Hong Kong SAR. Website: http://www.gov.hk (accessed 22 March 2014).
   Google Scholar
• Yang JY, Ye LY, Wang WW, Luo YP, Zhang YJ, Han L. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. Int J Antimicrob Agents 2011;38:348–51.
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Kim DM, Park WB, Lee KD, Kim HB, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase- producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004;25:860–7.
   PubMed Web of Science ®Google Scholar
• Tsay RW, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med 2002;162:1012–17.
   Google Scholar
• Liao CH, Lai CC, Hsu MS, Huang YT, Chu FY, Hsu HS, et al. Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study. Clin Microbiol Infect 2009;15:1119–25.
   PubMed Web of Science ®Google Scholar
• Mosqueda-Gómez JL, Montaño-Loza A, Rolón AL, Bobadilla-del-Valle JM, Silva-Sánchez J, Garza-Ramos U, et al. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: a case control study. Int J Infect Dis 2008;12:653–9.
   PubMedGoogle Scholar
• Kim BN, Woo JH, Kim MN, Ryu J, Kim YS. Clinical implications of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 2002;52: 99–106.
   PubMed Web of Science ®Google Scholar
• Kang CI, Chung DR, Ko KS, Peck KR, Song JH; Korean Network for Study of Infectious Diseases. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 2012;91:115–21.
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50: 1257–62.
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Kaye KS, Eliopoulos GM, Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 2002;162:185–90.
   PubMed Web of Science ®Google Scholar
• Blot S, Depuydt P, Vandewoude K, De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 2007;20:391–6.
   PubMed Web of Science ®Google Scholar
• El-Solh AA, Peter M, Alfarah Z, Akinnusi ME, Alabbas A, Pineda LA. Antibiotic prescription patterns in hospitalized patients with nursing home-acquired pneumonia. J Hosp Med 2010;5:E5–E10.
   Google Scholar
• Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 2012;38:1930–45.
   PubMed Web of Science ®Google Scholar
• You JH, Chow TC, Yeung AW, Lee N, Ip M. Acinetobacter baumannii bacteraemia in Hong Kong. J Hosp Infect 2010;75:81.
   Google Scholar
• You JH, Mok SS, Chang CC, Lee N, Ip M. Bacteremia with extended-spectrum β-lactamases-producing Escherichia coli in Hong Kong. Int J Antimicrob Agents 2009;34:615–16.
   Google Scholar
• Blot SI, Vandewoude KH, Colardyn FA. Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients. Eur J Clin Microbiol Infect Dis 2002;21:471–3.
   PubMed Web of Science ®Google Scholar